Science and Technology
We don't need another pretty-fabric re-do of what worked in the 19th Century. We need a new concept in respirators, based on the latest requirements and technologies.
We created a hybrid respirator that provides superior protection, is comfortable to use for extended periods, and is reusable without replacing filters.
What makes the OCTO® Respirator Mask different?
Superior Bi-Directional Protection
The antimicrobial filter material of the OCTO® Respirator Mask (ORM) effectively captures and starts killing pathogens on contact, while filtering over 97% of particulates in the atmosphere. The OCTO® Respirator Mask (ORM) is designed without a vent, to allow not only for filtration of the air inhaled (protecting the wearer), but the air exhaled as well (protecting those around).
We designed, built, and tested OCTO® Respirator Mask (ORM) to withstand boiling and autoclaving while maintaining its protective integrity, WITHOUT THE NEED OF REPLACEMENT FILTERS.
Most N95 face masks and N95 respirator masks available require breathing through the mouth, but the OCTO® Respirator Mask wearers can comfortably breathe through the nose with ease.
The strategically positioned vents allow clear communication and release CO2. It also provides proper heat dissipation and reduces moisture to minimize uncomfortable build-up inside the respirator.
Silicone Facial Skirt
Ultra-soft and lightweight silicone skirt allows extended wear of the OCTO® Respirator Mask (ORM). It is uniquely designed with three (3) seals to accommodate a wide variety of face shapes and sizes, enabling a proper seal of the ORM against the wearer’s face.
OCTO® Respirator Mask's particle filtration efficiency of filter material is tested on industry-standard TSI 8130 filter testing machines challenging it with particles of the most penetrating particle size range, 0.3 microns at 60 L/min flow rate. The test results show that our filter material has a filtration efficiency of over 97%.
Antimicrobial efficacy testing (JIS L 1902:2015) shows a 99.999990% reduction.
Antiviral efficacy testing (ISO 18184) shows a 98.92% reduction of Human Coronavirus 229E in the 2 hour test.
For professional use, please find technical information here.